# CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO)

> **NCT06972108** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Alberta** · enrollment: 20 (estimated)

## Conditions studied

- Meconium Aspiration Syndrome

## Interventions

- **DRUG:** Caffeine citrate
- **OTHER:** Saline (NaCl 0,9 %) (placebo)

## Key facts

- **NCT ID:** NCT06972108
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972108, "CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06972108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*